Archive for the ‘Adamis Pharmaceuticals’ Category

Adamis Pharmaceuticals Corp

August 22nd, 2013 | Posted in 2013, Adamis Pharmaceuticals

Adamis Pharmaceuticals Corporation, San Diego:  Recently announced that the technology that constitutes its compound APC-100 received notice of allowance for its patent application in the USA.  This is the final step in the issuance of a patent.

Adamis Pharmaceuticals

July 22nd, 2011 | Posted in 2011, Adamis Pharmaceuticals

Adamis Pharmaceuticals – San Diego:  Announced the technology that constitutes its compound APC-100 was recently granted a Patent in the USA.  The Patent, together with earlier-issued European and U.S. Patents, strengthens the Adamis APC-100 Patent Portfolio for its use in thetreatment of early- and late-stage prostate cancer.  Claims include a method of inhibiting the growth […]